Davis RE

General

Full name : Davis Robert E

First name : Robert E

Mail : Parke-Davis Pharmaceutical Research Division, 2800 Plymouth Road, Ann Arbor. Mi 48105-2430

Zip Code :

City :

Country : USA

Email :

Phone : (l) 3139967637

Fax : (l) 313 996 7178

Website :

Directory :

References (19)

Title : Genome and secretome analysis of the hemibiotrophic fungal pathogen, Moniliophthora roreri, which causes frosty pod rot disease of cacao: mechanisms of the biotrophic and necrotrophic phases - Meinhardt_2014_BMC.Genomics_15_164
Author(s) : Meinhardt LW , Costa GG , Thomazella DP , Teixeira PJ , Carazzolle MF , Schuster SC , Carlson JE , Guiltinan MJ , Mieczkowski P , Farmer A , Ramaraj T , Crozier J , Davis RE , Shao J , Melnick RL , Pereira GA , Bailey BA
Ref : BMC Genomics , 15 :164 , 2014
PubMedID: 24571091
Gene_locus related to this paper: monro-v2wn76 , monro-v2xuz8 , monro-v2xl67 , monro-v2xnp4 , monro-v2wv67 , monro-v2wja9

Title : Silencing of germline-expressed genes by DNA elimination in somatic cells - Wang_2012_Dev.Cell_23_1072
Author(s) : Wang J , Mitreva M , Berriman M , Thorne A , Magrini V , Koutsovoulos G , Kumar S , Blaxter ML , Davis RE
Ref : Dev Cell , 23 :1072 , 2012
PubMedID: 23123092
Gene_locus related to this paper: ascsu-f1kr69 , ascsu-f1kxs8 , ascsu-f1ky57 , ascsu-f1kze8 , ascsu-f1kzv8 , ascsu-f1kzx8 , ascsu-f1l0a5 , ascsu-f1l0j3 , ascsu-f1l0s5 , ascsu-f1l1m9 , ascsu-f1l2e5 , ascsu-f1l3k2 , ascsu-f1l7s2 , ascsu-f1l145 , ascsu-u1mei8 , ascsu-u1ns34 , ascsu-u1nb30 , ascsu-f1kzg5 , ascsu-u1ntf1 , ascsu-u1nx87 , ascsu-f1l5f0 , ascsu-f1l6n2

Title : AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model - Bradley_2010_Neuropharmacol_58_365
Author(s) : Bradley SR , Lameh J , Ohrmund L , Son T , Bajpai A , Nguyen D , Friberg M , Burstein ES , Spalding TA , Ott TR , Schiffer HH , Tabatabaei A , McFarland K , Davis RE , Bonhaus DW
Ref : Neuropharmacology , 58 :365 , 2010
PubMedID: 19835892

Title : Sequence-variable mosaics: composites of recurrent transposition characterizing the genomes of phylogenetically diverse phytoplasmas - Jomantiene_2007_DNA.Cell.Biol_26_557
Author(s) : Jomantiene R , Zhao Y , Davis RE
Ref : DNA & Cell Biology , 26 :557 , 2007
PubMedID: 17688407
Gene_locus related to this paper: 9molu-a8qwc7

Title : Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine: evidence for three distinct modes of receptor activation - Spalding_2006_Mol.Pharmacol_70_1974
Author(s) : Spalding TA , Ma JN , Ott TR , Friberg M , Bajpai A , Bradley SR , Davis RE , Brann MR , Burstein ES
Ref : Molecular Pharmacology , 70 :1974 , 2006
PubMedID: 16959945

Title : The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine - Weiner_2004_Psychopharmacology.(Berl)_177_207
Author(s) : Weiner DM , Meltzer HY , Veinbergs I , Donohue EM , Spalding TA , Smith TT , Mohell N , Harvey SC , Lameh J , Nash N , Vanover KE , Olsson R , Jayathilake K , Lee M , Levey AI , Hacksell U , Burstein ES , Davis RE , Brann MR
Ref : Psychopharmacology (Berl) , 177 :207 , 2004
PubMedID: 15258717

Title : CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology - Tecle_2000_Pharm.Acta.Helv_74_141
Author(s) : Tecle H , Schwarz RD , Barrett SD , Callahan MJ , Caprathe BW , Davis RE , Doyle P , Emmerling M , Lauffer DJ , Mirzadegan T , Moreland DW , Lipiniski W , Nelson C , Raby C , Spencer C , Spiegel K , Thomas AJ , Jaen JC
Ref : Pharm Acta Helv , 74 :141 , 2000
PubMedID: 10812951

Title : Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3'-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist - Tecle_1998_J.Med.Chem_41_2524
Author(s) : Tecle H , Barrett SD , Lauffer DJ , Augelli-Szafran C , Brann MR , Callahan MJ , Caprathe BW , Davis RE , Doyle PD , Eubanks D , Lipiniski W , Mirzadegan T , Moos WH , Moreland DW , Nelson CB , Pavia MR , Raby C , Schwarz RD , Spencer CJ , Thomas AJ , Jaen JC
Ref : Journal of Medicinal Chemistry , 41 :2524 , 1998
PubMedID: 9651157

Title : Poster: Aryleneyne 1-azabicyclo[2.2.1]heptan-3-one oximes: Potent muscarinic agonists -
Author(s) : Tecle H , Lauffer DJ , Davis RE , Mirzadegan T , Moreland DW , Schwarz RD , Thomas AJ , Raby C , Jaen JC
Ref : Life Sciences , 56(11-12) :1003 , 1995
PubMedID:

Title : Cholinergic therapies for Alzheimer's disease. Palliative or disease altering? - Davis_1995_Arzneimittelforschung_45_425
Author(s) : Davis RE , Doyle PD , Carroll RT , Emmerling MR , Jaen J
Ref : Arzneimittelforschung , 45 :425 , 1995
PubMedID: 7763338

Title : PD 142676 (CI 1002), a novel anticholinesterase and muscarinic antagonist - Emmerling_1994_Mol.Neurobiol_9_93
Author(s) : Emmerling MR , Gregor VE , Schwarz RD , Scholten JD , Callahan MJ , Lee C , Moore CJ , Raby C , Lipinski WJ , Davis RE
Ref : Molecular Neurobiology , 9 :93 , 1994
PubMedID: 7888109

Title : Synthesis and SAR of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists - Tecle_1993_Life.Sci_52(5-6)_505
Author(s) : Tecle H , Lauffer DJ , Mirzadegan T , Moos WH , Moreland DW , Pavia MR , Schwarz RD , Davis RE
Ref : Life Sciences , 52 :505 , 1993
PubMedID: 8382765

Title : Characterization of muscarinic agonists in recombinant cell lines - Schwarz_1993_Life.Sci_52(5-6)_465
Author(s) : Schwarz RD , Davis RE , Jaen JC , Spencer CJ , Tecle H , Thomas AJ
Ref : Life Sciences , 52 :465 , 1993
PubMedID: 8382764

Title : Cholinergic agents: effect of methyl substitution in a series of arecoline derivatives on binding to muscarinic acetylcholine receptors - Moos_1992_J.Pharm.Sci_81_1015
Author(s) : Moos WH , Bergmeier SC , Coughenour LL , Davis RE , Hershenson FM , Kester JA , McKee JS , Marriott JG , Schwarz RD , Tecle H , Thomas AJ
Ref : J Pharm Sci , 81 :1015 , 1992
PubMedID: 1432612

Title : Poster: Pharmacology of tacrine: comparisons with other cholinesterase inhibitors -
Author(s) : Davis RE , Coughenour LL , Dudley DT , Pugsley TA , Schwarz RD , Moos WH
Ref : In: Cholinesterases: Structure, Function, Mechanism, Genetics, and Cell Biology , (Massoulie J, Barnard EA, Chatonnet A, Bacou F, Doctor BP, Quinn DM) American Chemical Society, Washington, DC :346 , 1991
PubMedID:

Title : Poster: Inhibition of rat acetyl- and butyrylcholinesterase activity by tacrine and related aminoacridines -
Author(s) : Schwarz RD , Spencer CJ , Davis RE , Moos WH , Pavia MR , Thomas AJ
Ref : In: Cholinesterases: Structure, Function, Mechanism, Genetics, and Cell Biology , (Massoulie J, Barnard EA, Chatonnet A, Bacou F, Doctor BP, Quinn DM) American Chemical Society, Washington, DC :343 , 1991
PubMedID:

Title : Next generation tacrine -
Author(s) : Schwarz RD , Davis RE , Gracon S , Hoover T , Moos WH , Pavia MR
Ref : Neurobiology of Aging , 12 :185 , 1991
PubMedID: 2052133

Title : Poster: CI-969: An orally active muscarinic receptor agonist related to arecoline -
Author(s) : Pavia MR , Schwarz AD , Coughenour LL , Davis RE , Dudley DT , Moos WH , Pugsley TA , Tecle H , Clark CA
Ref : Trends in Pharmacological Sciences , Suppl :100 , 1989
PubMedID: